Expression analysis of serum microRNAs in idiopathic pulmonary fibrosis.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Journal of Molecular Medicine

• Publication date

  2014-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/ijmm.2014.1712PMID 24676360
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of seven serum microRNAs from a genome‐wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas

  2013cited by this paper
• Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer

  2013cited by this paper
• Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression.

  2013cited by this paper
• Serum miR-21 and miR-155 expression in idiopathic pulmonary fibrosis

  2013cited by this paper
• miR-221/222 Targets Adiponectin Receptor 1 to Promote the Epithelial-to-Mesenchymal Transition in Breast Cancer

  2013cited by this paper
• Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte‐derived microRNA‐122

  2013cited by this paper
• Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer.

  2013cited by this paper
• High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer

  2012cited by this paper
• An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

  2012cited by this paper
• Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection

  2012cited by this paper
• Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer.

  2012cited by this paper
• Regulated microRNAs in the CSF of patients with multiple sclerosis

  2012cited by this paper
• Plasma miR-601 and miR-760 Are Novel Biomarkers for the Early Detection of Colorectal Cancer

  2012cited by this paper
• Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature

  2012cited by this paper
• MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer

  2012cited by this paper
• Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet.

  2012cited by this paper
• A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL

  2011cited by this paper
• Clinical course and prediction of survival in idiopathic pulmonary fibrosis.

  2011cited by this paper
• miR-125b, a Target of CDX2, Regulates Cell Differentiation through Repression of the Core Binding Factor in Hematopoietic Malignancies*

  2011cited by this paper
• The rising incidence of idiopathic pulmonary fibrosis in the UK

  2011cited by this paper
• miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis

  2010cited by this paper
• Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study.

  2010cited by this paper
• Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.

  2009cited by this paper
• Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury.

  2009cited by this paper
• Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis.

  2009cited by this paper
• Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma

  2008cited by this paper
• MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis

  2008cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• Analyzing real-time PCR data by the comparative CT method

  2008cited by this paper
• Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?

  2007cited by this paper
• Prognostic value of circulating KL‐6 in idiopathic pulmonary fibrosis

  2006cited by this paper

• Identification of glycolysis-related gene signatures for prognosis and therapeutic targeting in idiopathic pulmonary fibrosis

  2025cites this paper
• The role of epigenetic regulation in idiopathic pulmonary fibrosis.

  2025cites this paper
• Uncovering mirnomes of patients with interstitial lung diseases and an underlying autoimmune process

  2025cites this paper
• MiR-101-3p alleviates TGF-β1-induced fibrosis of renal tubular epithelial cells by inhibiting EZH2 in chronic kidney disease

  2025cites this paper
• The role of miR21 in pulmonary fibrosis and its potential as a therapeutic target

  2025cites this paper
• Current Understanding of Pulmonary Fibrosis: Pathogenesis, Diagnosis, and Therapeutic Approaches

  2025cites this paper
• Revisiting the role of MicroRNAs in the pathogenesis of idiopathic pulmonary fibrosis

  2024cites this paper
• Circulating MicroRNAs in Idiopathic Pulmonary Fibrosis: A Narrative Review

  2024influential citation
• Exploring the Relation Between Interstitial Lung Diseases and Chronic Periodontitis: A Systematic Review

  2024cites this paper
• Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis

  2023cites this paper
• Diagnostic value of circulating microRNA-21 in chronic lung allograft dysfunction after bilateral cadaveric and living-donor lobar lung transplantation.

  2023cites this paper
• Boosting therapeutic efficacy of mesenchymal stem cells in pulmonary fibrosis: The role of genetic modification and preconditioning strategies

  2023cites this paper
• Idiopathic Pulmonary Fibrosis Molecular Substrates Revealed by Competing Endogenous RNA Regulatory Networks

  2023cites this paper
• miRNA Expression in Fibroblastic Foci within Idiopathic Pulmonary Fibrosis Lungs Reveals Novel Disease-Relevant Pathways

  2023cites this paper
• Mechanism of LncRNA XIST/ miR-101-3p/ZEB1 axis in EMT associated with silicosis.

  2022cites this paper
• Molecular pathways and role of epigenetics in the idiopathic pulmonary fibrosis.

  2022cites this paper
• Effects of microRNA-101-3p on predicting pediatric acute respiratory distress syndrome and its role in human alveolar epithelial cell

  2022cites this paper
• miRNAs Contained in Extracellular Vesicles Cargo Contribute to the Progression of Idiopathic Pulmonary Fibrosis: An In Vitro Aproach

  2022cites this paper
• Alterations in plasma miR-21, miR-590, miR-192 and miR-215 in idiopathic pulmonary fibrosis and their clinical importance

  2022cites this paper
• IPF-Fibroblast Erk1/2 Activity Is Independent from microRNA Cluster 17-92 but Can Be Inhibited by Treprostinil through DUSP1

  2021cites this paper
• Biomarkers for interstitial lung disease and acute-onset diffuse interstitial lung disease in rheumatoid arthritis

  2021cites this paper
• Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn’s Disease: The Path From Bench to Bedside

  2021cites this paper
• Evaluation of microRNA expression in a sheep model for lung fibrosis

  2021cites this paper
• Idiopathic Pulmonary Comorbidities and Mechanisms

  2021cites this paper
• Decrypting the crosstalk of noncoding RNAs in the progression of IPF

  2020cites this paper
• Silencing of Long Non-Coding RNA X Inactive Specific Transcript (Xist) Contributes to Suppression of Bronchopulmonary Dysplasia Induced by Hyperoxia in Newborn Mice via microRNA-101-3p and the transforming growth factor-beta 1 (TGF-β1)/Smad3 Axis

  2020cites this paper
• [Clinical value of biomarkers in diagnosis and treatment of idiopathic pulmonary fibrosis].

  2020cites this paper
• [Clinical value of biomarkers in diagnosis and treatment of idiopathic pulmonary fibrosis].

  2020cites this paper
• Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p

  2020cites this paper
• Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside.

  2020cites this paper
• An efficient electrochemical assay for miR-3675-3p in human serum based on the nanohybrid of functionalized fullerene and metal-organic framework.

  2020cites this paper
• miR-184 targets TP63 to block idiopathic pulmonary fibrosis by inhibiting proliferation and epithelial–mesenchymal transition of airway epithelial cells

  2020cites this paper
• More than a Genetic Code: Epigenetics of Lung Fibrosis

  2020cites this paper
• Integrated Bioinformatic Approach to Identify Potential Biomarkers against Idiopathic Pulmonary Fibrosis

  2019cites this paper
• The MicroRNA miR-155 Is Essential in Fibrosis

  2019cites this paper
• microRNA-328 in exosomes derived from M2 macrophages exerts a promotive effect on the progression of pulmonary fibrosis via FAM13A in a rat model

  2019cites this paper
• Screening for aberrantly-expressed microRNAs in peripheral blood leukocytes from silicosis patients

  2019cites this paper
• Clinical values of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases.

  2019cites this paper
• Diagnostic Potential of Extracellular MicroRNA in Respiratory Diseases

  2018cites this paper
• Translational control of cardiac fibrosis

  2018cites this paper
• Upregulated has-miR-4516 as a potential biomarker for early diagnosis of dust-induced pulmonary fibrosis in patients with pneumoconiosis.

  2018cites this paper
• The role of microRNAs in chronic respiratory disease: recent insights

  2017cites this paper
• Lung cancer in patients with idiopathic pulmonary fibrosis.

  2017cites this paper
• MicroRNA expression signature and the therapeutic effect of the microRNA-21 antagomir in hypertrophic scarring

  2017cites this paper
• Current concepts of idiopathic pulmonary fibrosis : focus on biomarkers

  2017cites this paper
• MicroRNA‐29c Prevents Pulmonary Fibrosis by Regulating Epithelial Cell Renewal and Apoptosis

  2017cites this paper
• Plasma miRNA expression profiles in rheumatoid arthritis associated interstitial lung disease

  2017influential citation
• Down‐Regulation of miR‐19a as a Biomarker for Early Detection of Silicosis

  2016cites this paper
• Title : High-throughput profiling for discovery of non-coding RNA biomarkers of lung disease Running title : RNA biomarkers of lung disease

  2016cites this paper
• High-throughput profiling for discovery of non-coding RNA biomarkers of lung disease

  2016influential citation
• Early and late effects of prenatal corticosteroid treatment on the microRNA profiles of lung tissue in rats

  2016cites this paper
• MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis

  2016cites this paper
• [Modulation of TLR-4/MyD88 signaling cascade by miR-21 is involved in airway immunologic dysfunction induced by cold air exposure].

  2016cites this paper
• Targeting miR-155 to Treat Experimental Scleroderma

  2016cites this paper
• Targeting MicroRNA Function in Respiratory Diseases: Mini-Review

  2016influential citation
• Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis

  2016cites this paper
• Recent advances in understanding idiopathic pulmonary fibrosis

  2016cites this paper
• The code of non-coding RNAs in lung fibrosis

  2015cites this paper
• Idiopathic pulmonary fibrosis biomarkers: clinical utility and a way of understanding disease pathogenesis

  2015cites this paper
• The case for epigenomics in idiopathic pulmonary fibrosis

  2015cites this paper
• Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.

  2015cites this paper
• Integrative analyses of miRNA and proteomics identify potential biological pathways associated with onset of pulmonary fibrosis in the bleomycin rat model.

  2015cites this paper
• Epigenetic Modifications in Fibrotic Diseases: Implications for Pathogenesis and Pharmacological Targets

  2015influential citation
• Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night

  2015cites this paper
• MicroRNA-215 Regulates Fibroblast Function: Insights from a Human Fibrotic Disease

  2015cites this paper
• Epigenetic targets for novel therapies of lung diseases.

  2015cites this paper